Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001610 · ClinicalTrials.gov registry record

Normal Human Electro-Oculogram

A clinical trial, sponsored by National Eye Institute (NEI).

Completed
Registry status
150
Enrollment target

NCT00001610 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001610 has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
150 participants
Enrollment target

Study Summary

This study will measure the normal range of the human electro-oculogram (EOG) in people of various age groups. EOGs are recordings of electrical signals generated by the retina (the light-sensitive tissue in the back of the eye) when going from a dark to a bright environment. They provide valuable information about the function of the eye in health and disease. A knowledge of what results are to be expected in tests of normal, healthy eyes will be valuable in assessing EOG results in patients with known or suspected retinal diseases. Normal volunteers from ages 6 to 65 who have healthy eyes and normal eyesight will participate in this study. Candidates will undergo tests to check vision and the health of the eye. Study participants will then have an electro-oculogram. In this test, eye drops are placed in the eye to enlarge the pupils. Two electrodes (small disks that picks up electrical signals) are attached to the left and right of each eye and one to the forehead. (These are similar to electrodes placed on the body during an electrocardiogram (ECG), which measures electrical signals from the heart.) During the EOG recording, the volunteer looks at the inside of a hollow sphere, following with their eyes small red lights that turn on and off. The background light is also turned on or off during the test. Some volunteers may be asked to repeat the EOG at another time. Study participants may also be asked to provide a blood sample for tests to study how the immune cells in the blood respond to proteins found in the retina. The response from normal volunteers will be compared with that of patients with eye diseases like retinitis pigmentosa.

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 1997-02
Est. Completion 2003-03

Sponsor

National Eye Institute (NEI)

221 total trials

What the Registry Record Tells You About NCT00001610

The ClinicalTrials.gov registry entry for NCT00001610 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001610 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001610 about?

NCT00001610 is a clinical study titled "Normal Human Electro-Oculogram". This study will measure the normal range of the human electro-oculogram (EOG) in people of various age groups. EOGs are recordings of electrical signals generated by the retina (the light-sensitive tissue in the back of the eye) when going from a dark to a bright environment. They provide valuable i...

What is the current status of trial NCT00001610?

This trial is currently completed. The enrollment target is 150 participants. The study started on 1997-02. Estimated completion is 2003-03.

Who is sponsoring clinical trial NCT00001610?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.